Skip to main content.

MemorialCare Participating in I-SPY COVID Trial to Evaluate Treatments for Severely-Ill COVID-19 Patients

Friday, February 05, 2021

Main News Photo

MemorialCare Long Beach Medical Center continues its fight against COVID-19 as a participant in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID Therapeutic Response with Biomarker Integration and Adaptive Learning). The focus of the trial is to improve outcomes for severely-ill COVID-19 patients.

The I-SPY COVID Trial is an adaptive platform trial that incorporates a single-study structure to evaluate multiple treatments independently within the same trial. This method allows for the rapid assessment of potentially impactful therapies. All patients admitted to the hospital with COVID-19 requiring high flow oxygen or mechanical ventilation are screened for potential participation in this trial. If a patient meets inclusion criteria and provides consent, they are randomized into one of several study arms, either offering established standard of care or one of several unique treatment options in addition to the established standard of care. The patient’s medical outcome will be closely evaluated, offering valuable data on the safety and efficacy of the various treatment options included in the study.

MemorialCare’s research team is led by board-certified pulmonologist, internist, and critical care specialist, and Principal Investigator Fady Youssef, M.D.

“This unique study design allows us to test several agents at once. The data is then quickly analyzed and a determination is made as to whether to advance the agent into a bigger trial or consider an Emergency Use Authorization Request if the results prove to be truly astounding,” explains Dr. Youssef. “The I-SPY study provides us a window into how future trials may be conducted, and we are hopeful that it will help us identify efficacious therapies that can potentially alter the course of this pandemic.”

Sponsored by Quantum Leap Healthcare Collaborative, the study is a collaboration among pharmaceutical industry members of the recently formed COVID Research & Development Alliance and others; a partnership of medical clinicians and researchers; and the Food and Drug Administration. For more information about the study, please visit Quantum Leap Healthcare Collaborative: I-SPY COVID (quantumleaphealth.org)

MemorialCare is a platinum-level Leaders Circle partner of the Greater Irvine Chamber.

Category: Partner News, Leaders Circle, Health Care, Greater Irvine Chamber, COVID-19

Skip Business Directory Content
Skip Fast Fact Content

Back to Portal